Artillery Shell Shortage Fiasco Deepens In Texas

July 15, 2026

A $500 million Texas artillery plant was supposed to help solve a shell shortage, but it still had not produced a single qualifying projectile nearly two years after opening.

Quick Take

The Mesquite facility opened in 2024, but lawmakers said it still had not made a qualifying 155 millimeter projectile.
The Army lifted an eight-month work stoppage in April 2026 and kept the $591 million contract moving.
General Dynamics later said it would spend $200 million of its own money to reboot the plant and end its partnership with Repkon.
The case shows how big defense contracts can miss goals for years while officials and contractors argue over fault.

Why the Plant Became a Test Case

The Mesquite plant was built to help the Army raise 155 millimeter shell output to 100,000 rounds a month. Instead, the facility cost more than $500 million and still had not produced a single qualifying projectile by early 2026, according to congressional and media reports. That gap matters because the Army’s own supply needs remain high, and the plant was supposed to be part of the answer.

Rep. Rob Wittman said in February 2026 that the facility had “yet to produce a single projectile,” and he said the production lines were not fully operational. A later Defense Department Inspector General report said the shortfall was tied in part to the failure of the Mesquite contractor-operated plant to produce a shell meeting Army specifications. Those findings turned the plant into a public symbol of delay, cost, and weak results.

What the Army Did Next

The Army did not shut the project down. Bloomberg reported that it lifted a work-stoppage order on April 3 after eight months and said it would move ahead with the $591 million contract. A separate report said the military was still in talks with General Dynamics and had not made a final termination decision. That choice shows how hard it can be to punish a major contractor when the service still needs the production capacity.

The Army also sent General Dynamics a cure notice over poor performance at the Mesquite site, according to a senior acquisition official. A show cause letter earlier warned that the company had missed deadlines for the first three Universal Artillery Projectile Lines. Together, those steps show a contract under pressure, but not one that had been canceled. The government wanted answers, yet it kept the deal alive.

General Dynamics Tries a Reset

General Dynamics later said it would invest $200 million of its own money and unwind its partnership with Turkish contractor Repkon. Bloomberg reported that the company planned to replace failed equipment with hardware and management from Deterrence Defense. That move suggests the company sees the problem as technical and fixable, not as a dead project. It also gives the firm a chance to argue that the plant can still become useful.

""A Pentagon watchdog report found that in the roughly two years since it was built, an ammunition plant in Mesquite, Texas, has not produced any parts for 155mm artillery rounds"https://t.co/37cyJ6dlyy

— AncloteYakker (@AncloteYakker) July 14, 2026

Still, the public record leaves one big question open: when will the plant actually produce qualifying shells? Some reports said the site was making around 56,000 shells a month, while others said it had made none under the Army deal. That mismatch could mean different things, such as casings versus approved projectiles, but the sources do not fully settle it. For readers, the larger issue is simple: a costly plant was built to deliver speed, and it still has not met the mission.